276 related articles for article (PubMed ID: 15046031)
1. [Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction].
Hayashi M
J Cardiol; 2004 Feb; 43(2):88-91. PubMed ID: 15046031
[TBL] [Abstract][Full Text] [Related]
2. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
[TBL] [Abstract][Full Text] [Related]
3. Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction.
Hayashi M; Tsutamoto T; Wada A; Maeda K; Mabuchi N; Tsutsui T; Matsui T; Fujii M; Matsumoto T; Yamamoto T; Horie H; Ohnishi M; Kinoshita M
J Am Coll Cardiol; 2001 Nov; 38(5):1375-82. PubMed ID: 11691511
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
5. [Mineralocorticoid receptor antagonist spironolactone improves left ventricular remodeling in patients with congestive heart failure and acute myocardial infarction].
Tsutamoto T
Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):90-100. PubMed ID: 15277727
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.
Tsukashita M; Marui A; Nishina T; Yoshikawa E; Kanemitsu H; Wang J; Ikeda T; Komeda M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):58-64. PubMed ID: 18603054
[TBL] [Abstract][Full Text] [Related]
7. Does spironolactone have a dose-dependent effect on left ventricular remodeling in patients with preserved left ventricular function after an acute myocardial infarction?
Vatankulu MA; Bacaksiz A; Sonmez O; Alihanoglu Y; Koc F; Demir K; Gul EE; Turfan M; Tasal A; Kayrak M; Yazici M; Ozdemir K
Cardiovasc Ther; 2013 Aug; 31(4):224-9. PubMed ID: 22963506
[TBL] [Abstract][Full Text] [Related]
8. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
Rodríguez JA; Godoy I; Castro P; Quintana JC; Chávez E; Yovanovich J; Corbalán R; Chávez A
Rev Med Chil; 1997 Jun; 125(6):643-52. PubMed ID: 9515282
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.
Orea-Tejeda A; Colín-Ramírez E; Castillo-Martínez L; Asensio-Lafuente E; Corzo-León D; González-Toledo R; Rebollar-González V; Narváez-David R; Dorantes-García J
Rev Invest Clin; 2007; 59(2):103-7. PubMed ID: 17633796
[TBL] [Abstract][Full Text] [Related]
10. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F
Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Horie H; Sugimoto Y; Kinoshita M
J Am Coll Cardiol; 2000 Sep; 36(3):838-44. PubMed ID: 10987608
[TBL] [Abstract][Full Text] [Related]
13. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Matsui T; Kinoshita M
J Am Coll Cardiol; 2001 Apr; 37(5):1228-33. PubMed ID: 11300427
[TBL] [Abstract][Full Text] [Related]
14. [Effect of spironolactone on left ventricular remodeling in patients with acute myocardial infarction].
Dong Q; Liu KS; Liu HB; Li SR; Han YP; Zhang LP; Wang Y; Liu G; Wang XP; Xu LF; Li XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):315-9. PubMed ID: 15932659
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
[TBL] [Abstract][Full Text] [Related]
16. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?
Pitt B
J Card Fail; 2002 Dec; 8(6 Suppl):S491-3. PubMed ID: 12555163
[TBL] [Abstract][Full Text] [Related]
17. Impact of mineralocorticoid receptor antagonists on changes in cardiac structure and function of left ventricular dysfunction: a meta-analysis of randomized controlled trials.
Li X; Qi Y; Li Y; Zhang S; Guo S; Chu S; Gao P; Zhu D; Wu Z; Lu L; Shen W; Jia N; Niu W
Circ Heart Fail; 2013 Mar; 6(2):156-65. PubMed ID: 23400891
[TBL] [Abstract][Full Text] [Related]
18. Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction.
Weir RA; Murphy CA; Petrie CJ; Martin TN; Balmain S; Clements S; Steedman T; Wagner GS; Dargie HJ; McMurray JJ
Circ Cardiovasc Imaging; 2010 Jul; 3(4):360-7. PubMed ID: 20348438
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?
Weir RA; Mark PB; Petrie CJ; Clements S; Steedman T; Ford I; Ng LL; Squire IB; Wagner GS; McMurray JJ; Dargie HJ
Am Heart J; 2009 Jun; 157(6):1088-96. PubMed ID: 19464421
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.
Modena MG; Aveta P; Menozzi A; Rossi R
Am Heart J; 2001 Jan; 141(1):41-6. PubMed ID: 11136485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
